Medical Science Liaison, OH/MI/W. PA, ViiV Healthcare, Research Triangle Park, North Carolina, USA.
Department of Pharmacy, Loma Linda University Health, Loma Linda, California, USA.
Clin Infect Dis. 2022 May 15;74(Suppl_3):e23-e33. doi: 10.1093/cid/ciac081.
Clinicians, researchers, and the public frequently turn to digital channels and social media for up-to-the-minute information on novel therapeutics and vaccines. The value of credible infectious diseases drug information is more apparent in the setting of the coronavirus disease 2019 (COVID-19) pandemic. This viewpoint by the Society of Infectious Diseases Pharmacists (SIDP) provides guidance on utilizing social media platforms to optimize infectious diseases pharmacotherapy. It includes tips for all levels of users but primarily serves a guide for the infectious diseases clinician who has not yet joined social media. It compares various social media platforms and suggests which to begin with based on user needs, recommends efficient curation of social media content, and outlines a stepwise approach (shown below) to increasing engagement over time. This summary will hopefully spur further quality content and engagement regarding drug information from the infectious diseases social media network.
临床医生、研究人员和公众经常通过数字渠道和社交媒体获取有关新型治疗方法和疫苗的最新信息。在 2019 冠状病毒病(COVID-19)大流行背景下,可信的传染病药物信息更具价值。本文由感染病药学协会(SIDP)撰写,旨在为利用社交媒体平台优化传染病药物治疗提供指导。本文面向各级用户,但主要针对尚未加入社交媒体的感染病临床医生。本文比较了各种社交媒体平台,并根据用户需求建议从哪个平台开始,还推荐了高效管理社交媒体内容的方法,并概述了一个逐步提高参与度的方法(见下文)。希望本文能够激发传染病社交媒体网络发布更多高质量的药物信息内容并提高其参与度。